Lv3
350 积分 2024-04-15 加入
Abstract P4-12-21: Efficacy and Safety of MRG002 in Prior TKI-Treated HER2 Positive Breast Cancer Patients: A Single Arm, Open Label, Multicenter, Phase II Study
19小时前
求助中
Abstract P4-12-21: Efficacy and Safety of MRG002 in Prior TKI-Treated HER2 Positive Breast Cancer Patients: A Single Arm, Open Label, Multicenter, Phase II Study
21小时前
求助中
Abstract P4-12-21: Efficacy and Safety of MRG002 in Prior TKI-Treated HER2 Positive Breast Cancer Patients: A Single Arm, Open Label, Multicenter, Phase II Study
1天前
求助中
First-in-human, dose-escalation, phase (ph) I trial to evaluate safety of anti-Axl antibody-drug conjugate (ADC) enapotamab vedotin (EnaV) in solid tumors
1天前
求助中
Signaling Pathways in Pancreatic Cancer
2个月前
已完结
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
2个月前
已完结
Signalling in pancreatic cancer: from pathways to therapy
2个月前
已完结
PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
6个月前
已完结
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
1年前
已完结
皖公网安备34019202002308
